SBI Securities »

Design Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $145 10 14.50

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Apple (AAPL)
Micron Technology (MU)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Direxion Daily Semi Bull 3X ETF Etf (SOXL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)

View all positions for SBI Securities

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Baker Bros. Advisors
Driehaus Capital Management
BlackRock
Caption Management
Point72 Asset Management
Trails Edge Capital Partners
Frazier Life Sciences Management
Vivo Capital
Vanguard Capital Management
Almitas Capital
Geode Capital Management
Sofinnova Ventures
FMR

View all funds holding Design Therapeutics